

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cytoplasmic mRNA processing body assembly (GO:0033962) | 5.25748286 |
| 2 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 4.91447215 |
| 3 | regulation of translation, ncRNA-mediated (GO:0045974) | 4.91447215 |
| 4 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 4.91447215 |
| 5 | mitotic sister chromatid cohesion (GO:0007064) | 4.85607371 |
| 6 | nuclear pore complex assembly (GO:0051292) | 4.75340182 |
| 7 | histone H3-K36 demethylation (GO:0070544) | 4.64116149 |
| 8 | monoubiquitinated protein deubiquitination (GO:0035520) | 4.60992251 |
| 9 | labyrinthine layer development (GO:0060711) | 4.52568161 |
| 10 | histone H3-K4 trimethylation (GO:0080182) | 4.51095629 |
| 11 | histone H3-K9 methylation (GO:0051567) | 4.42872191 |
| 12 | histone H3-K9 modification (GO:0061647) | 4.29219201 |
| 13 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 4.20338127 |
| 14 | cellular response to ethanol (GO:0071361) | 4.00659335 |
| 15 | nuclear pore organization (GO:0006999) | 3.99151989 |
| 16 | peptidyl-lysine trimethylation (GO:0018023) | 3.89909905 |
| 17 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.80848399 |
| 18 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.79836822 |
| 19 | histone demethylation (GO:0016577) | 3.64820148 |
| 20 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.58039275 |
| 21 | snRNA transcription (GO:0009301) | 3.56350398 |
| 22 | positive regulation of granulocyte differentiation (GO:0030854) | 3.52972698 |
| 23 | peptidyl-lysine methylation (GO:0018022) | 3.48419054 |
| 24 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 3.48127655 |
| 25 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 3.48127655 |
| 26 | B cell receptor signaling pathway (GO:0050853) | 3.46834786 |
| 27 | histone lysine methylation (GO:0034968) | 3.45505533 |
| 28 | negative regulation of DNA repair (GO:0045738) | 3.42336716 |
| 29 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 3.30999003 |
| 30 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 3.30999003 |
| 31 | pore complex assembly (GO:0046931) | 3.29575856 |
| 32 | neural tube formation (GO:0001841) | 3.27036095 |
| 33 | positive regulation of developmental pigmentation (GO:0048087) | 3.22233589 |
| 34 | regulation of histone H3-K9 methylation (GO:0051570) | 3.20595950 |
| 35 | protein K48-linked deubiquitination (GO:0071108) | 3.17610361 |
| 36 | protein dealkylation (GO:0008214) | 3.17075335 |
| 37 | protein demethylation (GO:0006482) | 3.17075335 |
| 38 | histone lysine demethylation (GO:0070076) | 3.13094253 |
| 39 | dosage compensation (GO:0007549) | 3.09965643 |
| 40 | positive regulation of mRNA processing (GO:0050685) | 3.07323792 |
| 41 | establishment of protein localization to Golgi (GO:0072600) | 3.06864715 |
| 42 | positive T cell selection (GO:0043368) | 3.05302094 |
| 43 | histone H3-K4 methylation (GO:0051568) | 3.04502696 |
| 44 | hepatocyte apoptotic process (GO:0097284) | 3.04484470 |
| 45 | N-terminal protein amino acid acetylation (GO:0006474) | 3.04237349 |
| 46 | pre-miRNA processing (GO:0031054) | 3.02040122 |
| 47 | protein K11-linked deubiquitination (GO:0035871) | 2.99925110 |
| 48 | regulation of Rac protein signal transduction (GO:0035020) | 2.99739099 |
| 49 | negative regulation of B cell proliferation (GO:0030889) | 2.99703937 |
| 50 | regulation of RNA export from nucleus (GO:0046831) | 2.98583482 |
| 51 | peptidyl-lysine dimethylation (GO:0018027) | 2.98581057 |
| 52 | definitive hemopoiesis (GO:0060216) | 2.97380076 |
| 53 | negative regulation of neurotransmitter transport (GO:0051589) | 2.96726090 |
| 54 | histone mRNA catabolic process (GO:0071044) | 2.95941598 |
| 55 | toxin transport (GO:1901998) | 2.95722735 |
| 56 | microtubule anchoring (GO:0034453) | 2.94670028 |
| 57 | positive regulation of mRNA 3-end processing (GO:0031442) | 2.94501915 |
| 58 | regulation of histone H3-K27 methylation (GO:0061085) | 2.92384942 |
| 59 | regulation of establishment of cell polarity (GO:2000114) | 2.91342665 |
| 60 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.89891964 |
| 61 | rRNA catabolic process (GO:0016075) | 2.89512379 |
| 62 | lipid translocation (GO:0034204) | 2.86358807 |
| 63 | phospholipid translocation (GO:0045332) | 2.86358807 |
| 64 | regulation of pigment cell differentiation (GO:0050932) | 2.85551919 |
| 65 | histone H3-K9 demethylation (GO:0033169) | 2.84970846 |
| 66 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.84065799 |
| 67 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.84065799 |
| 68 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.76974876 |
| 69 | regulation of chromatin silencing (GO:0031935) | 2.76421470 |
| 70 | carnitine transmembrane transport (GO:1902603) | 2.75092637 |
| 71 | positive regulation of mRNA catabolic process (GO:0061014) | 2.74986717 |
| 72 | regulation of gamma-delta T cell activation (GO:0046643) | 2.74084590 |
| 73 | positive regulation of mRNA metabolic process (GO:1903313) | 2.71404614 |
| 74 | negative T cell selection (GO:0043383) | 2.70492426 |
| 75 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 2.66577487 |
| 76 | negative thymic T cell selection (GO:0045060) | 2.65953486 |
| 77 | determination of adult lifespan (GO:0008340) | 2.65344253 |
| 78 | regulation of mRNA catabolic process (GO:0061013) | 2.64091372 |
| 79 | interkinetic nuclear migration (GO:0022027) | 2.60387022 |
| 80 | pericardium development (GO:0060039) | 2.60151748 |
| 81 | protein targeting to lysosome (GO:0006622) | 2.58375656 |
| 82 | establishment of protein localization to vacuole (GO:0072666) | 2.58375656 |
| 83 | protein targeting to vacuole (GO:0006623) | 2.58375656 |
| 84 | histone methylation (GO:0016571) | 2.57259106 |
| 85 | sister chromatid cohesion (GO:0007062) | 2.57022776 |
| 86 | regulation of mRNA 3-end processing (GO:0031440) | 2.56208858 |
| 87 | ventricular septum morphogenesis (GO:0060412) | 2.56038531 |
| 88 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.55985631 |
| 89 | regulation of necroptotic process (GO:0060544) | 2.55218264 |
| 90 | carnitine transport (GO:0015879) | 2.54450156 |
| 91 | amino-acid betaine transport (GO:0015838) | 2.54450156 |
| 92 | nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) | 2.52696636 |
| 93 | V(D)J recombination (GO:0033151) | 2.52374144 |
| 94 | microtubule nucleation (GO:0007020) | 2.51840798 |
| 95 | replicative senescence (GO:0090399) | 2.51064930 |
| 96 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.50648426 |
| 97 | protein K63-linked deubiquitination (GO:0070536) | 2.50027280 |
| 98 | histone-serine phosphorylation (GO:0035404) | 2.48809376 |
| 99 | embryonic process involved in female pregnancy (GO:0060136) | 2.48598914 |
| 100 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.47241575 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 4.68653576 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.33396662 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.03499751 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.97273859 |
| 5 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.85352139 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.77138226 |
| 7 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.68788490 |
| 8 | GATA1_22025678_ChIP-Seq_K562_Human | 2.64378768 |
| 9 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.41670659 |
| 10 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.39586565 |
| 11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.08556446 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.04318691 |
| 13 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.01052724 |
| 14 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.94272683 |
| 15 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.92401618 |
| 16 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.90479743 |
| 17 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.88460570 |
| 18 | MYB_26560356_Chip-Seq_TH2_Human | 1.81061937 |
| 19 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.76414965 |
| 20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.76387311 |
| 21 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.76358782 |
| 22 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.75128444 |
| 23 | EWS_26573619_Chip-Seq_HEK293_Human | 1.74134653 |
| 24 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.72198928 |
| 25 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.71343040 |
| 26 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.69902350 |
| 27 | TP53_16413492_ChIP-PET_HCT116_Human | 1.69463302 |
| 28 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.64538461 |
| 29 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.63568175 |
| 30 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.59890905 |
| 31 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.57476753 |
| 32 | MYB_26560356_Chip-Seq_TH1_Human | 1.55573734 |
| 33 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.54663309 |
| 34 | FUS_26573619_Chip-Seq_HEK293_Human | 1.51020312 |
| 35 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.48584847 |
| 36 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.48226156 |
| 37 | STAT3_23295773_ChIP-Seq_U87_Human | 1.42140386 |
| 38 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.41798665 |
| 39 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.41481912 |
| 40 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.38875207 |
| 41 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.38681610 |
| 42 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.37567792 |
| 43 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.37300349 |
| 44 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.36869563 |
| 45 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.36601253 |
| 46 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.36013281 |
| 47 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.34183345 |
| 48 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.31738075 |
| 49 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.31549183 |
| 50 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.30371363 |
| 51 | MYC_22102868_ChIP-Seq_BL_Human | 1.28392261 |
| 52 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.26345526 |
| 53 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.26018744 |
| 54 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.23775282 |
| 55 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.23116863 |
| 56 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.23023919 |
| 57 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.23023919 |
| 58 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.22979379 |
| 59 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.22861119 |
| 60 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.21668770 |
| 61 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.19633045 |
| 62 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.19335477 |
| 63 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.18480233 |
| 64 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.17946487 |
| 65 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.17561351 |
| 66 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.16776254 |
| 67 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.16643072 |
| 68 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.16127863 |
| 69 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.15940344 |
| 70 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.15511932 |
| 71 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.14894295 |
| 72 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14894295 |
| 73 | P300_19829295_ChIP-Seq_ESCs_Human | 1.14058191 |
| 74 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.12065255 |
| 75 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.08696744 |
| 76 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.08599958 |
| 77 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.07829223 |
| 78 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.07579552 |
| 79 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.07051963 |
| 80 | TCF4_23295773_ChIP-Seq_U87_Human | 1.06058358 |
| 81 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.05912119 |
| 82 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.03625463 |
| 83 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.02535697 |
| 84 | GATA3_26560356_Chip-Seq_TH2_Human | 1.02369413 |
| 85 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.01954763 |
| 86 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.00872450 |
| 87 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.00142767 |
| 88 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.99659322 |
| 89 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99190473 |
| 90 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.98908872 |
| 91 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.98039079 |
| 92 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.96349292 |
| 93 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.95753187 |
| 94 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.95700087 |
| 95 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95274309 |
| 96 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.93656655 |
| 97 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.93006050 |
| 98 | RXR_22108803_ChIP-Seq_LS180_Human | 0.92374577 |
| 99 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92091791 |
| 100 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.91739690 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008057_abnormal_DNA_replication | 7.59346267 |
| 2 | MP0000569_abnormal_digit_pigmentation | 5.82487560 |
| 3 | MP0002009_preneoplasia | 3.47112734 |
| 4 | MP0003787_abnormal_imprinting | 2.94713924 |
| 5 | MP0003763_abnormal_thymus_physiology | 2.66698952 |
| 6 | MP0000383_abnormal_hair_follicle | 2.46976846 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.36091038 |
| 8 | MP0002396_abnormal_hematopoietic_system | 2.32510118 |
| 9 | MP0010307_abnormal_tumor_latency | 2.27885364 |
| 10 | MP0003890_abnormal_embryonic-extraembry | 2.24801399 |
| 11 | MP0005083_abnormal_biliary_tract | 2.18759725 |
| 12 | MP0002166_altered_tumor_susceptibility | 2.14846988 |
| 13 | MP0004381_abnormal_hair_follicle | 2.08973494 |
| 14 | MP0008877_abnormal_DNA_methylation | 2.06346574 |
| 15 | MP0010678_abnormal_skin_adnexa | 2.04291363 |
| 16 | MP0005076_abnormal_cell_differentiation | 1.97890082 |
| 17 | MP0004808_abnormal_hematopoietic_stem | 1.88968361 |
| 18 | MP0010352_gastrointestinal_tract_polyps | 1.86797209 |
| 19 | MP0009697_abnormal_copulation | 1.72875820 |
| 20 | MP0003077_abnormal_cell_cycle | 1.66721635 |
| 21 | MP0004484_altered_response_of | 1.62818535 |
| 22 | MP0000703_abnormal_thymus_morphology | 1.62485290 |
| 23 | MP0001800_abnormal_humoral_immune | 1.61024311 |
| 24 | MP0003828_pulmonary_edema | 1.59635621 |
| 25 | MP0010094_abnormal_chromosome_stability | 1.46404089 |
| 26 | MP0000427_abnormal_hair_cycle | 1.45373733 |
| 27 | MP0002398_abnormal_bone_marrow | 1.44424564 |
| 28 | MP0000689_abnormal_spleen_morphology | 1.39110157 |
| 29 | MP0005310_abnormal_salivary_gland | 1.38391079 |
| 30 | MP0001545_abnormal_hematopoietic_system | 1.37131368 |
| 31 | MP0005397_hematopoietic_system_phenotyp | 1.37131368 |
| 32 | MP0008961_abnormal_basal_metabolism | 1.36803955 |
| 33 | MP0008995_early_reproductive_senescence | 1.34917936 |
| 34 | MP0003656_abnormal_erythrocyte_physiolo | 1.32081160 |
| 35 | MP0002722_abnormal_immune_system | 1.31895989 |
| 36 | MP0008058_abnormal_DNA_repair | 1.30960501 |
| 37 | MP0002006_tumorigenesis | 1.26865340 |
| 38 | MP0000015_abnormal_ear_pigmentation | 1.26837299 |
| 39 | MP0000716_abnormal_immune_system | 1.17241549 |
| 40 | MP0005075_abnormal_melanosome_morpholog | 1.16084957 |
| 41 | MP0003045_fibrosis | 1.11764619 |
| 42 | MP0009115_abnormal_fat_cell | 1.11345232 |
| 43 | MP0001879_abnormal_lymphatic_vessel | 1.10762113 |
| 44 | MP0003091_abnormal_cell_migration | 1.10234479 |
| 45 | MP0002132_abnormal_respiratory_system | 1.09460839 |
| 46 | MP0003111_abnormal_nucleus_morphology | 1.05882196 |
| 47 | MP0003221_abnormal_cardiomyocyte_apopto | 1.05782580 |
| 48 | MP0004130_abnormal_muscle_cell | 1.05382328 |
| 49 | MP0003121_genomic_imprinting | 1.04827517 |
| 50 | MP0002420_abnormal_adaptive_immunity | 1.04592049 |
| 51 | MP0002088_abnormal_embryonic_growth/wei | 1.01773816 |
| 52 | MP0003786_premature_aging | 1.01517502 |
| 53 | MP0003984_embryonic_growth_retardation | 1.01452783 |
| 54 | MP0005266_abnormal_metabolism | 1.01216691 |
| 55 | MP0001819_abnormal_immune_cell | 1.01098784 |
| 56 | MP0002452_abnormal_antigen_presenting | 0.98154725 |
| 57 | MP0003724_increased_susceptibility_to | 0.97770430 |
| 58 | MP0003646_muscle_fatigue | 0.96396597 |
| 59 | MP0002405_respiratory_system_inflammati | 0.95834380 |
| 60 | MP0002723_abnormal_immune_serum | 0.94462796 |
| 61 | MP0002019_abnormal_tumor_incidence | 0.93968434 |
| 62 | MP0002429_abnormal_blood_cell | 0.92600259 |
| 63 | MP0005174_abnormal_tail_pigmentation | 0.91884432 |
| 64 | MP0004883_abnormal_blood_vessel | 0.91880190 |
| 65 | MP0002086_abnormal_extraembryonic_tissu | 0.91122222 |
| 66 | MP0002928_abnormal_bile_duct | 0.88574132 |
| 67 | MP0008007_abnormal_cellular_replicative | 0.88425638 |
| 68 | MP0001851_eye_inflammation | 0.86868227 |
| 69 | MP0009278_abnormal_bone_marrow | 0.86440238 |
| 70 | MP0000685_abnormal_immune_system | 0.85938707 |
| 71 | MP0004134_abnormal_chest_morphology | 0.85907042 |
| 72 | MP0004185_abnormal_adipocyte_glucose | 0.83453146 |
| 73 | MP0005621_abnormal_cell_physiology | 0.83354525 |
| 74 | MP0000516_abnormal_urinary_system | 0.82655751 |
| 75 | MP0005367_renal/urinary_system_phenotyp | 0.82655751 |
| 76 | MP0003567_abnormal_fetal_cardiomyocyte | 0.82426397 |
| 77 | MP0001661_extended_life_span | 0.82253736 |
| 78 | MP0000371_diluted_coat_color | 0.81530371 |
| 79 | MP0005380_embryogenesis_phenotype | 0.80979469 |
| 80 | MP0001672_abnormal_embryogenesis/_devel | 0.80979469 |
| 81 | MP0002332_abnormal_exercise_endurance | 0.79885805 |
| 82 | MP0001915_intracranial_hemorrhage | 0.79448006 |
| 83 | MP0003300_gastrointestinal_ulcer | 0.76643097 |
| 84 | MP0005000_abnormal_immune_tolerance | 0.76297454 |
| 85 | MP0000350_abnormal_cell_proliferation | 0.74363321 |
| 86 | MP0001873_stomach_inflammation | 0.74348391 |
| 87 | MP0005646_abnormal_pituitary_gland | 0.74318802 |
| 88 | MP0003943_abnormal_hepatobiliary_system | 0.71588737 |
| 89 | MP0010630_abnormal_cardiac_muscle | 0.69451568 |
| 90 | MP0003866_abnormal_defecation | 0.68933391 |
| 91 | MP0001697_abnormal_embryo_size | 0.67695443 |
| 92 | MP0003252_abnormal_bile_duct | 0.67172803 |
| 93 | MP0002168_other_aberrant_phenotype | 0.66304054 |
| 94 | MP0005187_abnormal_penis_morphology | 0.65924797 |
| 95 | MP0004197_abnormal_fetal_growth/weight/ | 0.65502679 |
| 96 | MP0001784_abnormal_fluid_regulation | 0.65143533 |
| 97 | MP0003115_abnormal_respiratory_system | 0.62874237 |
| 98 | MP0005220_abnormal_exocrine_pancreas | 0.62830715 |
| 99 | MP0002925_abnormal_cardiovascular_devel | 0.61678078 |
| 100 | MP0005384_cellular_phenotype | 0.60263608 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the fingertips (HP:0001211) | 4.27015575 |
| 2 | Neonatal hypoglycemia (HP:0001998) | 3.96966195 |
| 3 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.60415183 |
| 4 | Genetic anticipation (HP:0003743) | 3.43652245 |
| 5 | Chromsome breakage (HP:0040012) | 3.37083556 |
| 6 | T lymphocytopenia (HP:0005403) | 3.34527961 |
| 7 | Acute myeloid leukemia (HP:0004808) | 3.12527218 |
| 8 | Abnormality of T cell number (HP:0011839) | 3.01218721 |
| 9 | Narrow palate (HP:0000189) | 2.99312693 |
| 10 | Spontaneous hematomas (HP:0007420) | 2.98630574 |
| 11 | Overgrowth (HP:0001548) | 2.97045116 |
| 12 | Heterotopia (HP:0002282) | 2.95025756 |
| 13 | Papillary thyroid carcinoma (HP:0002895) | 2.90748069 |
| 14 | Amyotrophic lateral sclerosis (HP:0007354) | 2.90435917 |
| 15 | Chronic hepatic failure (HP:0100626) | 2.87349826 |
| 16 | Truncal obesity (HP:0001956) | 2.87226722 |
| 17 | Abnormality of the nasal septum (HP:0000419) | 2.86683744 |
| 18 | Neoplasm of the adrenal cortex (HP:0100641) | 2.74062740 |
| 19 | Colitis (HP:0002583) | 2.74019935 |
| 20 | Fair hair (HP:0002286) | 2.70313280 |
| 21 | Abnormality of chromosome stability (HP:0003220) | 2.68839095 |
| 22 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.60427800 |
| 23 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.57587020 |
| 24 | Acute lymphatic leukemia (HP:0006721) | 2.51699270 |
| 25 | IgM deficiency (HP:0002850) | 2.50327093 |
| 26 | Partial agenesis of the corpus callosum (HP:0001338) | 2.48210088 |
| 27 | Sandal gap (HP:0001852) | 2.46590957 |
| 28 | Dysmetric saccades (HP:0000641) | 2.44714922 |
| 29 | Prominent nose (HP:0000448) | 2.43016557 |
| 30 | Hematochezia (HP:0002573) | 2.40958171 |
| 31 | Protruding tongue (HP:0010808) | 2.39493668 |
| 32 | Gaze-evoked nystagmus (HP:0000640) | 2.39216085 |
| 33 | Progressive cerebellar ataxia (HP:0002073) | 2.36090240 |
| 34 | Macroorchidism (HP:0000053) | 2.35960639 |
| 35 | Abnormality of the lower motor neuron (HP:0002366) | 2.35637555 |
| 36 | Volvulus (HP:0002580) | 2.35046703 |
| 37 | IgA deficiency (HP:0002720) | 2.34066865 |
| 38 | Deep philtrum (HP:0002002) | 2.30284364 |
| 39 | Recurrent viral infections (HP:0004429) | 2.27018780 |
| 40 | Curly hair (HP:0002212) | 2.25836560 |
| 41 | Thyroiditis (HP:0100646) | 2.25719319 |
| 42 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.25552810 |
| 43 | Thyroid carcinoma (HP:0002890) | 2.23755692 |
| 44 | Subacute progressive viral hepatitis (HP:0006572) | 2.23728285 |
| 45 | Inflammation of the large intestine (HP:0002037) | 2.20212109 |
| 46 | Clubbing of toes (HP:0100760) | 2.17992376 |
| 47 | Long eyelashes (HP:0000527) | 2.17866242 |
| 48 | Viral hepatitis (HP:0006562) | 2.17437925 |
| 49 | Autoimmune hemolytic anemia (HP:0001890) | 2.16014313 |
| 50 | Thick eyebrow (HP:0000574) | 2.15651110 |
| 51 | Febrile seizures (HP:0002373) | 2.12974765 |
| 52 | Generalized hypopigmentation of hair (HP:0011358) | 2.12217854 |
| 53 | Lower limb hyperreflexia (HP:0002395) | 2.10958817 |
| 54 | Pseudobulbar signs (HP:0002200) | 2.06054502 |
| 55 | Alveolar cell carcinoma (HP:0006519) | 2.05595374 |
| 56 | Submucous cleft hard palate (HP:0000176) | 2.02540036 |
| 57 | Recurrent fungal infections (HP:0002841) | 2.02509942 |
| 58 | Stomach cancer (HP:0012126) | 2.00390247 |
| 59 | Aqueductal stenosis (HP:0002410) | 1.98303550 |
| 60 | Sparse lateral eyebrow (HP:0005338) | 1.97674591 |
| 61 | Panhypogammaglobulinemia (HP:0003139) | 1.97562694 |
| 62 | Recurrent bacterial skin infections (HP:0005406) | 1.97176367 |
| 63 | Glioma (HP:0009733) | 1.96132491 |
| 64 | Basal cell carcinoma (HP:0002671) | 1.95009758 |
| 65 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.94954147 |
| 66 | Gastrointestinal inflammation (HP:0004386) | 1.93236494 |
| 67 | Hypoplastic labia majora (HP:0000059) | 1.92331795 |
| 68 | Rhabdomyosarcoma (HP:0002859) | 1.90801072 |
| 69 | Abnormality of the labia majora (HP:0012881) | 1.90796737 |
| 70 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.90792902 |
| 71 | Hamartoma (HP:0010566) | 1.89789391 |
| 72 | Embryonal renal neoplasm (HP:0011794) | 1.88827512 |
| 73 | Diastasis recti (HP:0001540) | 1.88416444 |
| 74 | Abnormality of T cells (HP:0002843) | 1.88011055 |
| 75 | Recurrent cutaneous fungal infections (HP:0011370) | 1.87967066 |
| 76 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.87967066 |
| 77 | Abnormality of the astrocytes (HP:0100707) | 1.86600427 |
| 78 | Astrocytoma (HP:0009592) | 1.86600427 |
| 79 | Vitreoretinal degeneration (HP:0000655) | 1.83606105 |
| 80 | Widely spaced teeth (HP:0000687) | 1.83416713 |
| 81 | Cystic hygroma (HP:0000476) | 1.82304012 |
| 82 | Cafe-au-lait spot (HP:0000957) | 1.76972779 |
| 83 | Tetraparesis (HP:0002273) | 1.74317397 |
| 84 | Lip pit (HP:0100267) | 1.72846185 |
| 85 | Recurrent bronchitis (HP:0002837) | 1.71448259 |
| 86 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.70774512 |
| 87 | Hypoplasia of the thymus (HP:0000778) | 1.70635978 |
| 88 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.69805547 |
| 89 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.69526930 |
| 90 | Neurodegeneration (HP:0002180) | 1.68650210 |
| 91 | Polycythemia (HP:0001901) | 1.68162645 |
| 92 | Depressed nasal tip (HP:0000437) | 1.68145583 |
| 93 | Slow saccadic eye movements (HP:0000514) | 1.66992525 |
| 94 | Neoplasm of striated muscle (HP:0009728) | 1.66417803 |
| 95 | Increased number of teeth (HP:0011069) | 1.63664480 |
| 96 | Hypopigmentation of the fundus (HP:0007894) | 1.63632755 |
| 97 | Clumsiness (HP:0002312) | 1.63517268 |
| 98 | Abnormality of chromosome segregation (HP:0002916) | 1.62684333 |
| 99 | Poor coordination (HP:0002370) | 1.61852635 |
| 100 | Obsessive-compulsive behavior (HP:0000722) | 1.61578569 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.50828934 |
| 2 | CDK12 | 4.23780667 |
| 3 | AKT3 | 3.25491059 |
| 4 | BRD4 | 3.17741085 |
| 5 | BRSK2 | 3.16011421 |
| 6 | PBK | 2.99090933 |
| 7 | TAOK3 | 2.85843297 |
| 8 | MAP3K10 | 2.18800255 |
| 9 | SGK2 | 2.01734909 |
| 10 | MKNK2 | 1.97557389 |
| 11 | CAMK1D | 1.89603773 |
| 12 | CAMK1G | 1.73019978 |
| 13 | MAP3K6 | 1.65249914 |
| 14 | NLK | 1.64561734 |
| 15 | MELK | 1.62007279 |
| 16 | FGFR2 | 1.61725571 |
| 17 | SCYL2 | 1.55909891 |
| 18 | BMPR2 | 1.53077363 |
| 19 | ZAK | 1.45277528 |
| 20 | BTK | 1.42313522 |
| 21 | FGFR3 | 1.41968650 |
| 22 | TXK | 1.37337255 |
| 23 | SGK3 | 1.36897130 |
| 24 | ACVR1B | 1.36866331 |
| 25 | BLK | 1.24822810 |
| 26 | IKBKE | 1.16178736 |
| 27 | TEC | 1.15941660 |
| 28 | MAP4K1 | 1.08850934 |
| 29 | JAK1 | 1.08448468 |
| 30 | SGK494 | 1.08332759 |
| 31 | SGK223 | 1.08332759 |
| 32 | BMPR1B | 1.03512388 |
| 33 | MAP2K3 | 1.01303332 |
| 34 | WEE1 | 1.01262090 |
| 35 | MARK2 | 0.94849461 |
| 36 | MARK3 | 0.94383771 |
| 37 | MAPK7 | 0.88704119 |
| 38 | GRK6 | 0.87177508 |
| 39 | WNK1 | 0.87072192 |
| 40 | MKNK1 | 0.85715128 |
| 41 | RIPK4 | 0.83033350 |
| 42 | MAP3K7 | 0.77960358 |
| 43 | NEK9 | 0.77822217 |
| 44 | TRPM7 | 0.77544616 |
| 45 | TYK2 | 0.77085883 |
| 46 | CCNB1 | 0.73240112 |
| 47 | SYK | 0.73201580 |
| 48 | CHUK | 0.72913184 |
| 49 | ZAP70 | 0.71875438 |
| 50 | PRKCH | 0.71140198 |
| 51 | MAP2K4 | 0.69862666 |
| 52 | RET | 0.68888039 |
| 53 | PIM1 | 0.68587143 |
| 54 | CDK6 | 0.67170862 |
| 55 | STK11 | 0.67168049 |
| 56 | SGK1 | 0.66687156 |
| 57 | CAMKK2 | 0.66314001 |
| 58 | MAP3K2 | 0.66216035 |
| 59 | CDK3 | 0.65165954 |
| 60 | TNK2 | 0.64841780 |
| 61 | PIK3CA | 0.64486344 |
| 62 | IRAK1 | 0.63891776 |
| 63 | HCK | 0.62429546 |
| 64 | MAP3K4 | 0.61780364 |
| 65 | RPS6KB2 | 0.61259970 |
| 66 | LATS1 | 0.60016383 |
| 67 | FLT3 | 0.57250164 |
| 68 | BRSK1 | 0.57118294 |
| 69 | PLK4 | 0.56898727 |
| 70 | PIK3CG | 0.56534148 |
| 71 | ATR | 0.56330642 |
| 72 | MAP3K5 | 0.55037049 |
| 73 | CHEK1 | 0.54386550 |
| 74 | ITK | 0.53907404 |
| 75 | MTOR | 0.53906220 |
| 76 | ATM | 0.53085735 |
| 77 | IRAK4 | 0.52784147 |
| 78 | NEK6 | 0.52660560 |
| 79 | LCK | 0.52050028 |
| 80 | MAPK11 | 0.51787693 |
| 81 | CAMK4 | 0.51302898 |
| 82 | OBSCN | 0.50870965 |
| 83 | FER | 0.47798919 |
| 84 | STK4 | 0.47076727 |
| 85 | NUAK1 | 0.45800847 |
| 86 | DYRK1A | 0.44894478 |
| 87 | PDGFRB | 0.44463041 |
| 88 | JAK3 | 0.44355186 |
| 89 | MAP3K14 | 0.44345438 |
| 90 | YES1 | 0.43750928 |
| 91 | TGFBR1 | 0.42762967 |
| 92 | CDC7 | 0.42290946 |
| 93 | RPS6KB1 | 0.42100512 |
| 94 | CDK4 | 0.41153757 |
| 95 | FES | 0.41129445 |
| 96 | CSK | 0.40507578 |
| 97 | PRKD2 | 0.40255084 |
| 98 | PRKD3 | 0.39589243 |
| 99 | LYN | 0.39027710 |
| 100 | DYRK3 | 0.38893776 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.10675973 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.97885741 |
| 3 | Lysine degradation_Homo sapiens_hsa00310 | 1.96505070 |
| 4 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.76796744 |
| 5 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.73414878 |
| 6 | Prostate cancer_Homo sapiens_hsa05215 | 1.66997519 |
| 7 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.64541182 |
| 8 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.64490252 |
| 9 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.60155751 |
| 10 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.56388063 |
| 11 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.55800259 |
| 12 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.49479048 |
| 13 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.48702308 |
| 14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.48351683 |
| 15 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.45424344 |
| 16 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.45311244 |
| 17 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.44237667 |
| 18 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.43446293 |
| 19 | Endometrial cancer_Homo sapiens_hsa05213 | 1.42073076 |
| 20 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.41319356 |
| 21 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.40513051 |
| 22 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.37482397 |
| 23 | Colorectal cancer_Homo sapiens_hsa05210 | 1.36357143 |
| 24 | Measles_Homo sapiens_hsa05162 | 1.34917866 |
| 25 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.34307267 |
| 26 | Hepatitis B_Homo sapiens_hsa05161 | 1.32116432 |
| 27 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.31845736 |
| 28 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.27398064 |
| 29 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.25008177 |
| 30 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.22230463 |
| 31 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.21877201 |
| 32 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.20234292 |
| 33 | Glioma_Homo sapiens_hsa05214 | 1.20165330 |
| 34 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.18378221 |
| 35 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.18321826 |
| 36 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.17947781 |
| 37 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.17490195 |
| 38 | RNA degradation_Homo sapiens_hsa03018 | 1.15999869 |
| 39 | Leishmaniasis_Homo sapiens_hsa05140 | 1.14817319 |
| 40 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.14479571 |
| 41 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.12479778 |
| 42 | Homologous recombination_Homo sapiens_hsa03440 | 1.11938827 |
| 43 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.11320635 |
| 44 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.09217862 |
| 45 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.07984556 |
| 46 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.07349594 |
| 47 | Cell cycle_Homo sapiens_hsa04110 | 1.05944982 |
| 48 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.99186849 |
| 49 | Influenza A_Homo sapiens_hsa05164 | 0.98830461 |
| 50 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.98603178 |
| 51 | Platelet activation_Homo sapiens_hsa04611 | 0.98250880 |
| 52 | Alcoholism_Homo sapiens_hsa05034 | 0.97201421 |
| 53 | Adherens junction_Homo sapiens_hsa04520 | 0.96400782 |
| 54 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.96215365 |
| 55 | Insulin resistance_Homo sapiens_hsa04931 | 0.95449300 |
| 56 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.94313268 |
| 57 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.94089595 |
| 58 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.87847112 |
| 59 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.85021682 |
| 60 | HTLV-I infection_Homo sapiens_hsa05166 | 0.84773197 |
| 61 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.83355065 |
| 62 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.83237266 |
| 63 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.82043105 |
| 64 | Hepatitis C_Homo sapiens_hsa05160 | 0.81314311 |
| 65 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.80664080 |
| 66 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.78957145 |
| 67 | Tuberculosis_Homo sapiens_hsa05152 | 0.77781472 |
| 68 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.77241774 |
| 69 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.76841369 |
| 70 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.76689142 |
| 71 | Circadian rhythm_Homo sapiens_hsa04710 | 0.75188676 |
| 72 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.73639225 |
| 73 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.73619817 |
| 74 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.73253342 |
| 75 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.68218750 |
| 76 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.68060892 |
| 77 | Thyroid cancer_Homo sapiens_hsa05216 | 0.67912255 |
| 78 | DNA replication_Homo sapiens_hsa03030 | 0.67525151 |
| 79 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.66795247 |
| 80 | Long-term depression_Homo sapiens_hsa04730 | 0.65547139 |
| 81 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.64820029 |
| 82 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.63851690 |
| 83 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.62754934 |
| 84 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.61815819 |
| 85 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.59254742 |
| 86 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.58335187 |
| 87 | Apoptosis_Homo sapiens_hsa04210 | 0.57725540 |
| 88 | Taste transduction_Homo sapiens_hsa04742 | 0.57698006 |
| 89 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.57087190 |
| 90 | Long-term potentiation_Homo sapiens_hsa04720 | 0.55748121 |
| 91 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.55405816 |
| 92 | Pathways in cancer_Homo sapiens_hsa05200 | 0.55014099 |
| 93 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.53931333 |
| 94 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.53900497 |
| 95 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.53735573 |
| 96 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52249330 |
| 97 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.50984892 |
| 98 | ABC transporters_Homo sapiens_hsa02010 | 0.50571826 |
| 99 | Melanoma_Homo sapiens_hsa05218 | 0.48255450 |
| 100 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.45978179 |

